Cidara Therapeutics Inc
NASDAQ:CDTX

Watchlist Manager
Cidara Therapeutics Inc Logo
Cidara Therapeutics Inc
NASDAQ:CDTX
Watchlist
Price: 220.86 USD Market Closed
Market Cap: 6.9B USD

Wall Street
Price Targets

CDTX Price Targets Summary
Cidara Therapeutics Inc

Wall Street analysts forecast CDTX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDTX is 220.19 USD with a low forecast of 200.99 USD and a high forecast of 232.58 USD.

Lowest
Price Target
200.99 USD
9% Downside
Average
Price Target
220.19 USD
0% Downside
Highest
Price Target
232.58 USD
5% Upside
Cidara Therapeutics Inc Competitors:
Price Targets
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
47% Upside
TNG
Transgene SA
53% Upside
ALXO
ALX Oncology Holdings Inc
125% Upside
MIRM
Mirum Pharmaceuticals Inc
29% Upside
AZT
Arcticzymes Technologies ASA
54% Upside
ALKS
Alkermes Plc
57% Upside
ADAG
Adagene Inc
409% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Cidara Therapeutics Inc

The compound annual growth rate of Cidara Therapeutics Inc's revenue for the next 4 years is 318%.

N/A
Past Growth
318%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cidara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Cidara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CDTX's stock price target?
Price Target
220.19 USD

According to Wall Street analysts, the average 1-year price target for CDTX is 220.19 USD with a low forecast of 200.99 USD and a high forecast of 232.58 USD.

What is Cidara Therapeutics Inc's Revenue forecast?
Projected CAGR
318%

The compound annual growth rate of Cidara Therapeutics Inc's revenue for the next 4 years is 318%.

Back to Top